Impact of Persistent vs. Transient Conduction Abnormalities Within 7 Days Post-TAVR on Mortality: Results of a Single-Center Prospective Registry
See C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. Impact of Persistent vs. Transient Conduction Abnormalities Within 7 Days Post-TAVR on Mortality: Results of a Single-Center Prospective Registry. Cardiovascular Revascularization Medicine 2021, 28: s43. DOI: 10.1016/j.carrev.2021.06.099.Peer-Reviewed Original ResearchIMPACT OF PACEMAKER IMPLANT ≤ 30 DAYS POST TAVR ON MORTALITY: RESULTS OF A SINGLE CENTER PROSPECTIVE REGISTRY
See C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. IMPACT OF PACEMAKER IMPLANT ≤ 30 DAYS POST TAVR ON MORTALITY: RESULTS OF A SINGLE CENTER PROSPECTIVE REGISTRY. Journal Of The American College Of Cardiology 2021, 77: 974. DOI: 10.1016/s0735-1097(21)02333-0.Peer-Reviewed Original Research